Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and management of complement mediated thrombotic microangiopathies.

Blood reviews - 1 Mar 2014

Cataland Spero R, Wu Haifeng M

Abstract excerpt

Historically, attempts were made to differentiate acquired thrombotic thrombocytopenic purpura (TTP) from atypical hemolytic uremic syndrome (aHUS) based upon the age at presentation and the presence of neurologic or renal injury. Although these means of differentiating acquired TTP from aHUS have now been demonstrated to be inaccurate, there were no clinical consequences as the treatment for both disorders...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADAMTS13 Protein
Share to Complement Activation
Share to Complement C3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement C4

Share to Hemolytic-Uremic Syndrome

Share to Plasma Exchange

Share to Platelet Count

Share to Purpura, Thrombotic Thrombocytopenic

Source

Identifiers

PMID: 24534133
DOI: 10.1016/j.blre.2014.01.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and management of complement mediated thrombotic microangiopathies.PMID 24534133Read ↗

Consensus regarding diagnosis and management of atypical hemolytic uremic syndromeSemantic proximity Read ↗

Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment ApproachesSemantic proximity Read ↗

Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.Semantic proximity Read ↗

Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.Semantic proximity Read ↗

Atypical aHUS: State of the art.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy.Semantic proximity Read ↗

Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.Semantic proximity Read ↗

[Atypical hemolytic uremic syndrome].Semantic proximity Read ↗

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTPSemantic proximity Read ↗

A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.Semantic proximity Read ↗

How I diagnose and treat atypical hemolytic uremic syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.